Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
19.99
+2.19 (12.30%)
At close: Aug 13, 2025, 4:00 PM
18.71
-1.28 (-6.40%)
Pre-market: Aug 14, 2025, 9:07 AM EDT
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of $2.76 billion as of August 14, 2025. Its market cap has decreased by -22.36% in one year.
Market Cap
2.76B
Enterprise Value
2.58B
1-Year Change
-22.36%
Ranking
Category
Stock Price
$19.99
Market Cap Chart
Since June 30, 2004, Arrowhead Pharmaceuticals's market cap has increased from $95.40M to $2.76B, an increase of 2,797.03%. That is a compound annual growth rate of 17.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 2.76B | 18.14% |
Dec 31, 2024 | 2.34B | -28.84% |
Dec 29, 2023 | 3.29B | -23.54% |
Dec 30, 2022 | 4.30B | -37.84% |
Dec 31, 2021 | 6.92B | -11.95% |
Dec 31, 2020 | 7.86B | 29.67% |
Dec 31, 2019 | 6.06B | 451.13% |
Dec 31, 2018 | 1.10B | 299.42% |
Dec 29, 2017 | 275.20M | 154.58% |
Dec 30, 2016 | 108.10M | -70.48% |
Dec 31, 2015 | 366.20M | -9.27% |
Dec 31, 2014 | 403.60M | -3.88% |
Dec 31, 2013 | 419.90M | 1,153.43% |
Dec 31, 2012 | 33.50M | -24.04% |
Dec 30, 2011 | 44.10M | -31.42% |
Dec 31, 2010 | 64.30M | 93.09% |
Dec 31, 2009 | 33.30M | -15.70% |
Dec 31, 2008 | 39.50M | -72.93% |
Dec 31, 2007 | 145.90M | -2.60% |
Dec 29, 2006 | 149.80M | 25.99% |
Dec 30, 2005 | 118.90M | 101.87% |
Dec 31, 2004 | 58.90M | -38.26% |
View and export this data all the way back to 2004.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 592.95B |
Johnson & Johnson | 420.06B |
AbbVie | 355.91B |
UnitedHealth Group | 246.17B |
AstraZeneca | 240.81B |
Novartis AG | 234.72B |
Novo Nordisk | 227.37B |
Abbott Laboratories | 225.22B |